Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Integrated Protein Technologies
AddedFeb 18, 2024
UpdatedJun 18, 2026
Integrated Protein Technologies

Integrated Protein Technologies

Integrated Protein Technologies simplifies biomolecule workflows with user-friendly automation solutions.

HQ
Evanston, IL, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Integrated Protein Technologies (IPT) was founded with the mission to simplify biomolecule workflows through innovative automation solutions. The company's core product, the SampleStreamâ„¢ Platform, transforms complex intact biomolecule processes into user-friendly, sample-to-answer solutions. This platform is particularly suited for demanding applications in biopharma, laboratory-developed testing, and in vitro diagnostics, offering high throughput and flexible software to meet diverse needs.

Notable figures associated with IPT include Dan Goers. The company has made significant strides in the field of proteomics by providing a more efficient and streamlined approach to biomolecular sample preparation. Their impact is evident in the enhanced productivity and accuracy in biopharma and diagnostic laboratories, positioning IPT as a key player in workflow automation technology.

Integrated Protein Technologies - Similar Companies

Impact Proteomics logo

Impact Proteomics

Proteios Technology logo

Proteios Technology

proteios.com

IonDX logo

IonDX

iondx.com

DPX Technologies logo

DPX Technologies

Perfinity Biosciences logo

Perfinity Biosciences

perfinity.com

Protein Dynamic Solutions logo

Protein Dynamic Solutions

pdsbio.com

Integrated Plasmonics logo

Integrated Plasmonics

Ionpath logo

Ionpath

Fluidigm logo

Fluidigm

standardbio.com

Inso Biosciences logo

Inso Biosciences

inso.bio

ProteoWise logo

ProteoWise

proteowise.com

Nanostream logo

Nanostream

nanostream.com

Applied Proteomics logo

Applied Proteomics

Aqueduct Fluidics logo

Aqueduct Fluidics

Monomer Bio logo

Monomer Bio

monomerbio.com

Integrated Protein Technologies - Quick Facts

Who are Integrated Protein Technologies' competitors?

Companies similar to Integrated Protein Technologies include Impact Proteomics, Proteios Technology, IonDX and DPX Technologies.

When was Integrated Protein Technologies founded?

Integrated Protein Technologies was founded in 2011.

Where is Integrated Protein Technologies' headquarters located?

Integrated Protein Technologies' headquarters is located in Evanston, IL, US.

When was Integrated Protein Technologies' last funding round?

Integrated Protein Technologies' most recent funding round was for $224.2k (USD) in July 2017.

How much has Integrated Protein Technologies raised to-date?

As of Jul 10, 2017, Integrated Protein Technologies has raised a total of $224.2k (USD).

How many employees does Integrated Protein Technologies have?

Integrated Protein Technologies has 6 employees as of Feb 4, 2024.

Integrated Protein Technologies - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
Main Product
  • Automation
  • Software
Tags
  • Hardware
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software